Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells-Reference-Cited by-同舟云学术

Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells

Published:2009-05-01 Issue:5 Volume:119 Page:1109-1123
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Bellodi Cristian,Lidonnici Maria Rosa,Hamilton Ashley,Helgason G. Vignir,Soliera Angela Rachele,Ronchetti Mattia,Galavotti Sara,Young Kenneth W.,Selmi Tommaso,Yacobi Rinat,Van Etten Richard A.,Donato Nick,Hunter Ann,Dinsdale David,Tirrò Elena,Vigneri Paolo,Nicotera Pierluigi,Dyer Martin J.,Holyoake Tessa,Salomoni Paolo,Calabretta Bruno

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference75 articles.

1. Chronic myelogenous leukemia in blast crisis

2. Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16‐year period

3. The Chronic Myelogenous Leukemia-Specific P210 Protein Is the Product of the bcr / abl Hybrid Gene

4. Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis

Cited by 498 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms, Clinical Management and Innovative Treatment;Drug Design, Development and Therapy;2024-09

2. Is Autophagy Targeting a Valid Adjuvant Strategy in Conjunction with Tyrosine Kinase Inhibitors?;Cancers;2024-08-28

3. Risk factors of using late-autophagy inhibitors: Aspects to consider when combined with anticancer therapies;Biochemical Pharmacology;2024-07

4. Dissecting the multifaceted roles of autophagy in cancer initiation, growth, and metastasis: from molecular mechanisms to therapeutic applications;Medical Oncology;2024-06-20

5. Nutrient-sensitizing drug repurposing screen identifies lomerizine as a mitochondrial metabolism inhibitor of chronic myeloid leukemia;Science Translational Medicine;2024-06-12